• The Tenaquip Foundation Walk for Muscular Dystrophy raising funds, hope and unity in new ways

    The Tenaquip Foundation Walk for Muscular Dystrophy raising funds, hope and unity in new ways

    FOR IMMEDIATE RELEASE July 29, 2020 Toronto, Ontario – Muscular Dystrophy Canada (MDC) is bringing the neuromuscular community together like it never has before. On September 12, 2020 at 2 p.m. EST, thousands of Canadians across the country will come together, virtually, to participate in The Tenaquip Foundation Walk for Muscular Dystrophy (Walk4MD). “This is …Continue Reading
  • New Partnership Offers Access to Shared Decision Making Support in Ontario

    New Partnership Offers Access to Shared Decision Making Support in Ontario

    New partnership offers access to shared decision making support for paediatric clients and their families in Ontario For Immediate Release – June 23, 2020 Ontario, Canada – Muscular Dystrophy Canada (MDC), Children’s Hospital at London Health Sciences Centre (LHSC), and Children’s Health Foundation have entered into a partnership to offer a pilot project providing access …Continue Reading
  • New partnership will provide cough assists for adults in British Columbia

    New partnership will provide cough assists for adults in British Columbia

    Vancouver, British Columbia – British Columbians living with a neuromuscular disorder will soon be able to breathe easier thanks to a partnership between Muscular Dystrophy Canada (MDC) and Technology for Living (TFL). The partnership will provide cough assists for adults in BC, who do not have access to this critical piece of respiratory equipment, and …Continue Reading
  • Fire Fighters Fill the Boot Campaign Goes Virtual

    Fire Fighters Fill the Boot Campaign Goes Virtual

    For Immediate Release. May 5, 2020 Toronto, Ontario – For an incredible 65 years Fire Fighters across Canada have helped Fill the Boot. Unfortunately, due to COVID-19, Fire Fighters had to cancel their fundraising efforts this Spring, but the needs of people impacted by neuromuscular disorders can’t be cancelled. MDC still needs to provide critical …Continue Reading
  • Stacey Lintern appointed Interim CEO at Muscular Dystrophy Canada

    Stacey Lintern appointed Interim CEO at Muscular Dystrophy Canada

    For immediate release. April 27, 2020 Toronto, Ontario – The Board of Muscular Dystrophy Canada is pleased to announce the appointment of Stacey Lintern as interim Chief Executive Officer, effective April 22, 2020. Stacey has been with Muscular Dystrophy Canada since 2012, and has worked in the not-for-profit sector for over 20 years. She has …Continue Reading
  • Muscular Dystrophy Canada makes the difficult decision to reduce staff

    Muscular Dystrophy Canada makes the difficult decision to reduce staff

    For Immediate Release – April 8, 2020 Toronto, Ontario – Muscular Dystrophy Canada (MDC) announced that they have temporarily reduced their staff by 17 people in positions across the organization, at all levels. “We considered all our options before coming to this extremely difficult decision. Of paramount importance was our ability to maintain core services …Continue Reading
  • COVID – 19: What you should know about this novel coronavirus

    COVID – 19: What you should know about this novel coronavirus

    Given the recent updates on COVID-19, Muscular Dystrophy Canada has implemented a work from home policy, therefore, effective immediately all MDC offices are closed. Our staff remain available via email and telephone and will continue to serve our clients, volunteers, donors and other key stakeholders. During this difficult time, we remind everyone that social distancing …Continue Reading
  • Response to PMPRB Draft Guidelines Consultation

    Response to PMPRB Draft Guidelines Consultation

    February 14, 2020 Dr. Mitchell Levine Chairperson Patented Medicines Prices Review Board 333 Laurier Avenue West, Suite 1400 Ottawa, Ontario K1P 1C1 Email: PMPRB.Consultations.CEPMB@pmprb-cepmb.gc.ca Dear Dr. Levine: Muscular Dystrophy Canada is thankful for the invitation to attend the PMPRB Consultation meeting in Ottawa on December 10, 2019 and for the opportunity to respond to the …Continue Reading
  • NMD4C propelling research forward for patients, scientists and clinicians

    NMD4C propelling research forward for patients, scientists and clinicians

    FOR IMMEDIATE RELEASE – Friday, January 31, 2020 Toronto, Ontario – A new partnership between Muscular Dystrophy Canada (MDC) and the Canadian Institutes of Health Research (CIHR) announces the creation of a new neuromuscular network in Canada. Led by Dr. Hanns Lochmüller, NMD4C is an integrated research network for patients, scientists, and clinicians to improve …Continue Reading
  • Key topics in Spinal Muscular Atrophy research discussed at first ever Muscular Dystrophy Canada SMA Research Summit

    Key topics in Spinal Muscular Atrophy research discussed at first ever Muscular Dystrophy Canada SMA Research Summit

    Toronto, November 15, 2019 – Research experts, the medical community, and industry stakeholders came together in Toronto this week at the inaugural Muscular Dystrophy Canada (MDC) SMA Research Summit to discuss new research and development. “This summit was an important opportunity for us to review the latest developments and discuss where there are opportunities to …Continue Reading